DMC Biotechnologies

About:

DMC Biotechnologies produces bio-based chemicals using fermentation.

Twitter/X: DmcBiotech

Top Investors: National Science Foundation, Breakthrough Energy Ventures, Sofinnova Partners, Syensqo Ventures, Capricorn Partners

Description:

DMC Biotechnologies produces bio-based chemicals using fermentation. The company's technology makes products using lower energy and resources, with applications that contribute to a sustainable economy. DMC Biotechnologies, Inc. was founded in 2014 by Matt Lipscomb and Mike Lynch and is based in Boulder, Colorado, United States.

Total Funding Amount:

$53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2014-01-01

Founders:

Matt Lipscomb, Mike Lynch

Number of Employees:

51-100

Last Funding Date:

2021-12-02

IPO Status:

Private

Industries: